The FDA has approved Avance® (acellular nerve allograft-arwx) for the treatment of sensory nerve discontinuity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback